Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.5 to v3.6.6, indicating a new page revision for the study entry.
    Difference
    0.1%
    Check dated 2026-08-29T23:45:44.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.6.4 to v3.6.5, replacing the previous version in the revision history to indicate a small update to the page’s version tag.
    Difference
    0.1%
    Check dated 2026-08-08T23:54:28.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4. This indicates a new release of the page without changes to study content.
    Difference
    0.1%
    Check dated 2026-07-25T18:04:45.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3. This indicates an updated build/version of the ClinicalTrials.gov page without changes to its content or data.
    Difference
    0.1%
    Check dated 2026-07-04T13:07:12.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Platform revision updated from v3.6.0 to v3.6.2, indicating an updated build of the site. This change does not modify study data or visible content on the page.
    Difference
    0.1%
    Check dated 2026-06-27T06:23:43.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    The page now marks recruitment as closed ('No longer looking for participants') and adds user guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), while updating the revision label to v3.6.0 and standardizing the Intervention/Treatment heading (replacing Intervention / Treatment with Intervention/Treatment).
    Difference
    0.4%
    Check dated 2026-06-13T00:25:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.